Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Modulation of the IL-6/STAT3 Signaling Axis in CD4 + T Cells As a Potential Immune Mechanism of Action of Azacytidine in High-Risk Myelodysplastic Syndromes

Eleftheria Lamprianidou, Chrysoula Kordella, Anastasiya Kazachenka, Emmanouela Zoulia, Elsa Bernard, PhD, Anastasia Filia, Stamatia Laidou, Theodoros P. Vassilakopoulos, MD PhD, Sotirios Papageorgiou, MD PhD, Vassiliki Pappa, MD, Athanasios Galanopoulos, MD PhD, Nora-Athina Viniou, MD PhD, Evangelia Nakou, Anastasia Hadzidimitriou, PhD, George Kassiotis, Elli Papaemmanuil, PhD, Ioannis Mitroulis, Ioannis Kotsianidis

Blood (2019) 134 (Supplement_1): 2988.

https://doi.org/10.1182/blood-2019-126504

Published: 2019

Journal Articles

Complications and Toxicities Associated with Autologous Stem Cell Transplantation for Severe Autoimmune Diseases: Single Center Experience

Shona Philip, BSc, MSc, MD, Christopher Bredeson, MD FRCPC, MSc, David S. Allan, MD FRCPC, MSc, Sultan Altouri, MD FRCPC, Lothar B. Huebsch, MD, Harold Atkins, MD, Natasha Kekre, MD FRCPC

Blood (2018) 132 (Supplement 1): 4624.

https://doi.org/10.1182/blood-2018-99-119797

Published: 2018

Journal Articles

PCT3, a Combination of Active Steroidal Saponins from the Paris Forrestii (Takht.) H. Li, Displays Potent Activity Against Acute Myeloid Leukemia By Suppressing the PBX1/RNF6/AKT/mTOR Signaling Pathway

Qin Lu, MD, Yunjing Zheng, MD, Yuehu Wang, PhD, Jian Pan, PhD, Xinliang Mao, MD PhD, Shaoyan Hu, MD PhD

Blood (2017) 130 (Supplement 1): 2533.

https://doi.org/10.1182/blood.V130.Suppl_1.2533.2533

Published: 2017

Journal Articles

SL-401, a Novel IL-3Rα/CD123-Directed Agent Targets Stem-like Cells in Multiple Myeloma

Arghya Ray, PhD, Yan Song, PhD, Deepika Sharma Das, PhD, Vincent Macri, MA, Janice Chen, PhD, Claudia Paba-Praba, Paul G. Richardson, MD, Christopher L. Brooks, PhD, Dharminder Chauhan, PhD, Kenneth C. Anderson, MD

Blood (2016) 128 (22): 4463.

https://doi.org/10.1182/blood.V128.22.4463.4463

Published: 2016

Journal Articles

A Novel Agent SL-401 Triggers Anti-Myeloma Activity By Targeting Plasmacytoid Dendritic Cells: Implications for a Novel Immune-Associated Mechanism

Arghya Ray, PhD, Deepika Sharma DAS, PhD, Yan Song, PhD, Vincent Macri, MA, Christopher L. Brooks, PhD, Eric K. Rowinsky, MD, Paul G. Richardson, MD, Dharminder Chauhan, PhD, Kenneth C Anderson, MD

Blood (2015) 126 (23): 3000.

https://doi.org/10.1182/blood.V126.23.3000.3000

Published: 2015

Journal Articles

CD4+ T Cells in High-Risk MDS Patients Bear an Aberrant STAT Signaling Biosignature

Eleftheria Lamprianidou, Constantinos Tsatalas, Paraskevi Miltiades, Theodoros P. Vassilakopoulos, Sotirios G Papageorgiou, MD, Athanasios G. Galanopoulos, Sofia Vakalopoulou, MD Ass.Prof.Hematology, Vassilia Garypidou, Evangelia Nakou, Emmanuil Spanoudakis, Ioannis Kotsianidis

Blood (2014) 124 (21): 1906.

https://doi.org/10.1182/blood.V124.21.1906.1906

Published: 2014

Journal Articles

SL-401, a Novel Targeted Therapy Directed to the Interleukin-3 Receptor (IL-3R), Blocks Plasmacytoid Dendritic Cell (pDC)-Triggered Myeloma Cell Growth and Prevents Osteoclastogenesis

Arghya Ray, PhD, Deepika Sharma Das, PhD, Durgadevi Ravillah, PhD, Yan Song, PhD, Vincent Macri, Christopher Brooks, PhD, Eric Rowinsky, MD, Paul G. Richardson, Dharminder Chauhan, PhD, Kenneth C. Anderson, MD

Blood (2014) 124 (21): 3441.

https://doi.org/10.1182/blood.V124.21.3441.3441

Published: 2014

Journal Articles

Autologous Stem Cell Transplant for Myasthenia Gravis: A Single-Centre Experience

Adam Bryant, MD, Elizabeth Pringle, MD, Christopher Bredeson, MD MSc, FRCPC, David S. Allan, MD MSc, Grizel Anstee, Isabelle Bence-Bruckler, Linda Hamelin, Harry Spencer Hopkins, Lothar B. Huebsch, MD, Mitchell Sabloff, MDM, Dawn C. Sheppard, MDFRCPC,MSc, Jason Tay, MD MSc, Harold Atkins, MD

Blood (2014) 124 (21): 3996.

https://doi.org/10.1182/blood.V124.21.3996.3996

Published: 2014

Journal Articles

Distinct Profile and Epigenetic Modulation Of STAT Signaling In FOXP3+ T Regulatory Cells Among The Various MDS Subtypes

Eleftheria Lamprianidou, Costas Tsatalas, Paraskevi Miltiades, Theodoros Vassilakopoulos, Athanasios G. Galanopoulos, Sotirios G Papageorgiou, Vassilia Garypidou, Sofia Vakalopoulou, MD, Emmanouil Spanoudakis, Dimitrios Margaritis, Ioannis Kotsianidis

Blood (2013) 122 (21): 1509.

https://doi.org/10.1182/blood.V122.21.1509.1509

Published: 2013

Journal Articles

The Levels of a G-CSF-Inducible pSTAT3+pSTAT5+ Subpopulation of MDS Progenitors with Leukemic Stem Cell Phenotype Predict the Response to Azacytidine

Paraskevi Miltiades, Eleytheria Labrianidou, Theodoros P. Vassilakopoulos, Sotirios G Papageorgiou, Athanasios G. Galanopoulos, Sofia Vakalopoulou, MD, Ass.Prof.Hematology, Vassilia Garypidou, Evangelia Nakou, Emmanuil Spanoudakis, Maria Papaioannou, Helen A. Papadaki, MD, PhD, Vasiliki Pappa, Konstantinos Tsatalas, Ioannis Kotsianidis, MD, PhD

Blood (2012) 120 (21): 3795.

https://doi.org/10.1182/blood.V120.21.3795.3795

Published: 2012

Journal Articles

Costs Associated with the Care of Very Young Children with Sickle Cell Anemia (SCA): Analysis from the BABY HUG Study

Winfred C. Wang, MD, Suzette O. Oyeku, MD, MPH, Zhaoyu Luo, PhD, Sheree L. Boulet, Dr.P.H., M.P.H., Scott T. Miller, MD, Billie Fish, CCRP, Bruce W Thompson, PhD, Scott Grosse, PhD.

Blood (2011) 118 (21): 171.

https://doi.org/10.1182/blood.V118.21.171.171

Published: 2011

Journal Articles

Specificity of Markers of Leukemia Initiating Cells with a New Multiparameter Flow Cytometry Based Appraoch; Impact for Prognostic and Therapeutic Applications

Gerrit J. Schuurhuis, PhD, Rolf Wouters, Angèle Kelder, Arjo P Rutten, Alexander N Snel, Monique Terwijn, Paul Noordhuis, PhD, Sonja Zweegman, MD, PhD, Gert J. Ossenkoppele, MD, PhD

Blood (2010) 116 (21): 1834.

https://doi.org/10.1182/blood.V116.21.1834.1834

Published: 2010

Journal Articles

Alterations In the Signaling Profile of Leukemic Progenitors Can Predict the Response of Myelodysplastic Syndrome (MDS) Patients to Azacytidine

Paraskevi Miltiades, Irene Bouchliou, Evangelia Nakou, Emmanuil Spanoudakis, Sotirios Papageorgiou, Vasiliki Pappa, Maria Papaioannou, Eleytherios Moustakidis, Sofia Vakalopoulou, Vasilia Garipidou, Konstantinos Tsatalas, Ioannis Kotsianidis

Blood (2010) 116 (21): 2921.

https://doi.org/10.1182/blood.V116.21.2921.2921

Published: 2010

Journal Articles

Use of Intravenous Immunoglobulin for Treatment of Neurological Conditions: A Systematic Review.

Brian Hutton, MSc, Dean Fergusson, MHA, PhD, Michael Sharma, MD, Alan Tinmouth, MD, FRCPC, MSc, Kumanan Wilson, MD, MSc, Bill Cameron, MD, Paul C. Hebert, MD, FRCPC, MHSc

Blood (2004) 104 (11): 3642.

https://doi.org/10.1182/blood.V104.11.3642.3642

Published: 2004

Journal Articles

Soluble Monomeric P-Selectin Containing Only the Lectin and Epidermal Growth Factor Domains Binds to P-Selectin Glycoprotein Ligand-1 on Leukocytes

Padmaja Mehta, Kamala D. Patel, Thomas M. Laue, Harold P. Erickson, Rodger P. McEver

Blood (1997) 90 (6): 2381–2389.

https://doi.org/10.1182/blood.V90.6.2381

Published: 1997

NARROW

Modulation of the IL-6/STAT3 Signaling Axis in CD4 + T Cells As a Potential Immune Mechanism of Action of Azacytidine in High-Risk Myelodysplastic Syndromes

Complications and Toxicities Associated with Autologous Stem Cell Transplantation for Severe Autoimmune Diseases: Single Center Experience

PCT3, a Combination of Active Steroidal Saponins from the Paris Forrestii (Takht.) H. Li, Displays Potent Activity Against Acute Myeloid Leukemia By Suppressing the PBX1/RNF6/AKT/mTOR Signaling Pathway

SL-401, a Novel IL-3Rα/CD123-Directed Agent Targets Stem-like Cells in Multiple Myeloma

A Novel Agent SL-401 Triggers Anti-Myeloma Activity By Targeting Plasmacytoid Dendritic Cells: Implications for a Novel Immune-Associated Mechanism

CD4+ T Cells in High-Risk MDS Patients Bear an Aberrant STAT Signaling Biosignature

SL-401, a Novel Targeted Therapy Directed to the Interleukin-3 Receptor (IL-3R), Blocks Plasmacytoid Dendritic Cell (pDC)-Triggered Myeloma Cell Growth and Prevents Osteoclastogenesis

Autologous Stem Cell Transplant for Myasthenia Gravis: A Single-Centre Experience

Distinct Profile and Epigenetic Modulation Of STAT Signaling In FOXP3+ T Regulatory Cells Among The Various MDS Subtypes

The Levels of a G-CSF-Inducible pSTAT3+pSTAT5+ Subpopulation of MDS Progenitors with Leukemic Stem Cell Phenotype Predict the Response to Azacytidine

Costs Associated with the Care of Very Young Children with Sickle Cell Anemia (SCA): Analysis from the BABY HUG Study

Specificity of Markers of Leukemia Initiating Cells with a New Multiparameter Flow Cytometry Based Appraoch; Impact for Prognostic and Therapeutic Applications

Alterations In the Signaling Profile of Leukemic Progenitors Can Predict the Response of Myelodysplastic Syndrome (MDS) Patients to Azacytidine

Use of Intravenous Immunoglobulin for Treatment of Neurological Conditions: A Systematic Review.

Soluble Monomeric P-Selectin Containing Only the Lectin and Epidermal Growth Factor Domains Binds to P-Selectin Glycoprotein Ligand-1 on Leukocytes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only